Clinical Trial Update: Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel, cisplatin, and filgrastim with radiation therapy for locally recurrent head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Filgrastim (filgrastim)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED